Case Report: Itraconazole Oral Solution Continuous Therapy for Infantile Tinea Capitis

Area of Science:

• Dermatology
• Mycology
• Pediatrics

Background:

• Tinea capitis, a fungal infection, is common in children but rare in infants.
• Oral itraconazole is a standard treatment for tinea capitis, but its use in infants is limited.
• Previous research indicated itraconazole's effectiveness for infantile tinea capitis caused by Microsporum canis.

Observation:

• This study reports on four infants diagnosed with tinea capitis.
• Two infants had M. canis infections, one had Nannizzia gypsea, and one had Trichophyton tonsurans.
• All infants received continuous oral itraconazole solution therapy at 5 mg/kg/day.

Findings:

• Continuous itraconazole oral solution therapy proved effective in all four cases of infantile tinea capitis.
• The treatment demonstrated efficacy against M. canis, N. gypsea, and T. tonsurans.
• The safety profile of continuous itraconazole therapy in infants was also assessed.

Implications:

• Continuous itraconazole oral solution therapy is a viable and effective treatment option for infantile tinea capitis caused by a broader range of dermatophytes.
• This study expands the evidence base for using itraconazole in infants for fungal scalp infections.
• Further research may confirm these findings in larger pediatric populations.